SoftBank-backed Vir Biotechnology raises $143 million in U.S. IPO

  • Thursday, 10 October 2019
  • Posted by Aftab Ahmad
  • 0 Comments
Vir Biotechnology priced its initial public offering (IPO) at $20 a share on Thursday, at the bottom end of expectations, a fresh blow for SoftBank Group Corp's Vision Fund, owner of 21% in the infectious disease researcher.


from Reuters: Technology News https://ift.tt/2ovFXQk

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply